Search Results for "Alterna Cigs Free Trial"

22:57 EST 30th January 2015 | BioPortfolio

Matching Channels

Free perforation

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

Sexual Health

The World Health Organization (WHO) definition of sexual health; "the state of physical, emotional, mental and social well-being related to sexuality; it is not merely the absence of disease, d...

Vitamin E Toxicity

Research has not found any adverse effects from consuming vitamin E in food. However, high doses of alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation in animals, and ...

Matching News

Survey: E-cigs surpass regular cigs in teen use

E-Cigarettes May Be Safer, But They're Still Harmful

Rayshell Clapper for - Your Universe Online According to the Centers for Disease Control and Prevention (CDC), the single most easily preventable cause of death and disease is to elimina...

Survey: E-Cigs Surpass Regular Cigarettes in Teen Use

WASHINGTON (AP) — Electronic cigarettes have surpassed traditional smoking in popularity among teens, the government's annual drug use survey finds.Even as tobacco smoking by teens dropped to new lo...

Novartis drug prolongs progression-free survival in multiple myeloma trial

A late-stage trial showed Novartis Pharmaceuticals' panobinostat, in combination with bortezomib and dexamethasone, was more  -More- 

Agritek Holdings Inc. Announces New Research: E-Cigs Safer Alternative to Regular Cigarettes

LOS ANGELES, CA--(Marketwired - August 27, 2014) - Agritek Holdings, Inc. (OTCQB: AGTK) (, a fully reporting company on the OTCQB and leader in Compassionate Care Techn...

Regulate E-Cigs Sooner, Not Later

(MedPage Today) -- Experts call for carefully crafted regulatory control of e-cigarettes.

E-Cigarettes May Be Less Addictive

Brett Smith for - Your Universe Online While e-cigarette vendors seem to be everywhere these days, the jury is still out on whether or not they are a safer alternative to tobacco product...

e-Cigs: Consensus or Controversy?

A growing number of organizations have weighed in on the pros and cons of electronic cigarettes. Medscape Internal Medicine

Matching PubMed Articles

A study on the optics of copper indium gallium (di)selenide (CIGS) solar cells with ultra-thin absorber layers.

We present a systematic study of the effect of variation of the zinc oxide (ZnO) and copper indium gallium (di)selenide (CIGS) layer thickness on the absorption characteristics of CIGS solar cells usi...

Effectiveness of the Electronic Cigarette: An Eight-Week Flemish Study with Six-Month Follow-up on Smoking Reduction, Craving and Experienced Benefits and Complaints.

Smoking reduction remains a pivotal issue in public health policy, but quit rates obtained with traditional quit-smoking therapies remain disappointingly low. Tobacco Harm Reduction (THR), aiming at l...

Suppressing lossy-film-induced angular mismatches between reflectance and transmittance extrema: optimum optical designs of interlayers and AR coating for maximum transmittance into active layers of CIGS solar cells.

The investigation of optimum optical designs of interlayers and antireflection (AR) coating for achieving maximum average transmittance (Tave) into the CuIn1-xGaxSe2 (CIGS) absorber of a typical CIGS ...

Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit.

Electronic cigarettes (e-Cigs) are an attractive long-term alternative nicotine source to conventional cigarettes. Although they may assist smokers to remain abstinent during their quit attempt, studi...

Re-treatment with varenicline for smoking cessation in smokers who have previously taken varenicline: A randomized, placebo-controlled trial.

The efficacy and safety of re-treatment with varenicline in smokers attempting to quit was evaluated in this randomized, double-blind, placebo-controlled, multicenter trial (Australia, Belgium, Canada...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement